We are live on ! Find out more
MLAB icon

Mesa Laboratories

174 hedge funds and large institutions have $1.35B invested in Mesa Laboratories in 2020 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 59 increasing their positions, 59 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

550% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 4

14% more funds holding

Funds holding: 153174 (+21)

11% more capital invested

Capital invested by funds: $1.21B → $1.35B (+$135M)

0% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 59

1.68% less ownership

Funds ownership: 93.64%91.96% (-1.7%)

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
174
Holders Change
+21
Holders Change %
+13.73%
% of All Funds
3.08%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
26
Increased
59
Reduced
59
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
OAM
101
Oppenheimer Asset Management
New York
$598K +$61.4K +223 +12%
ClearBridge Investments
102
ClearBridge Investments
New York
$583K +$182K +662 +48%
VOYA Investment Management
103
VOYA Investment Management
Georgia
$582K +$171K +621 +44%
MIM
104
MetLife Investment Management
New Jersey
$579K
Victory Capital Management
105
Victory Capital Management
Texas
$573K +$69.1K +251 +14%
OPERF
106
Oregon Public Employees Retirement Fund
Oregon
$564K +$102K +369 +23%
MAM
107
Martingale Asset Management
Massachusetts
$546K -$2.31M -8,400 -82%
ECM
108
Everence Capital Management
Indiana
$545K -$102K -370 -16%
MSA
109
Mason Street Advisors
Wisconsin
$520K -$1.65K -6 -0.3%
Bank of Montreal
110
Bank of Montreal
Ontario, Canada
$518K +$257K +933 +110%
Two Sigma Investments
111
Two Sigma Investments
New York
$516K -$468K -1,700 -49%
State of Tennessee, Department of Treasury
112
State of Tennessee, Department of Treasury
Tennessee
$502K +$117K +424 +32%
FIM
113
Freedom Investment Management
Connecticut
$501K -$75.7K -275 -14%
Neuberger Berman Group
114
Neuberger Berman Group
New York
$484K -$3.55M -12,892 -88%
New York State Teachers Retirement System (NYSTRS)
115
New York State Teachers Retirement System (NYSTRS)
New York
$476K
State Board of Administration of Florida Retirement System
116
State Board of Administration of Florida Retirement System
Florida
$427K
LWAM
117
Legacy Wealth Asset Management
Minnesota
$424K +$407K +1,479 New
KTC
118
Kistler-Tiffany Companies
Pennsylvania
$420K
ASRS
119
Arizona State Retirement System
Arizona
$403K -$5.23K -19 -1%
MLICM
120
Metropolitan Life Insurance Company (MetLife)
New York
$397K
HighTower Advisors
121
HighTower Advisors
Illinois
$390K +$50.3K +183 +16%
MFIM
122
Mesirow Financial Investment Management
Illinois
$386K +$1.65K +6 +0.4%
6M
123
6 Meridian
Kansas
$360K -$3.58K -13 -1%
PAM
124
Panagora Asset Management
Massachusetts
$359K +$286K +1,041 +491%
ProShare Advisors
125
ProShare Advisors
Maryland
$327K +$314K +1,142 New

MLAB Hedge Fund Activity: Q4 2020 in Review

174 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q4 2020, worth a combined $1.35B — up 11% from $1.21B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new MLAB positions and 4 closed out — a net gain of 22 holders — while 59 added to existing stakes and 59 trimmed.

The largest buyer was BlackRock, adding an estimated $7.22M. The largest seller was Goldman Sachs, cutting an estimated $17.7M.

  • 174 institutional investors held Mesa Laboratories (MLAB) as of Q4 2020, up from 153 in Q3 2020.
  • Funds reported $1.35B of Mesa Laboratories stock for Q4 2020, up 11% quarter-over-quarter.
  • 26 funds opened new Mesa Laboratories positions in Q4 2020 and 4 closed out, a net change of +22 holders.
  • The largest Mesa Laboratories buyer in Q4 2020 was BlackRock, an estimated $7.22M added.
  • The largest Mesa Laboratories seller in Q4 2020 was Goldman Sachs, an estimated $17.7M sold.

Based on aggregated 13F filings for Q4 2020.